A vaccine designed to target two different forms of Covid will be offered as part of the autumn booster programme, after the jab was approved by the UK’s regulator.
Manufactured by the US firm Moderna, the jab attacks not only the original coronavirus – as is the case for vaccines currently in use – but is designed specifically for the Omicron variant BA.1, which fuelled a wave of the virus in the UK last winter.
